C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/1993
08/31/1993	US5240838 Genetic engineering
08/31/1993	US5240837 CDNAS encoding somatotropin, expression vectors and hosts
08/31/1993	US5240834 Solubilization of protein after bacterial expression using sarkosyl
08/31/1993	US5240832 Culturing cells transformed with vectors to produce thyroid stimulating hormone
08/31/1993	US5240706 Vaccine
08/31/1993	US5240705 Haemophilus paragallinarum vaccine
08/31/1993	US5240703 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
08/31/1993	CA1321766C Process for producing cell having high productivity of protein and process for preparing protein by using the cell
08/31/1993	CA1321765C Immunodiagnostic assays using chimeric antigens
08/31/1993	CA1321764C Dna sequence to target proteins to the mammary gland for efficient secretion
08/31/1993	CA1321763C Monoclonal antibody specific to human pancreatic phospholipase a
08/30/1993	CA2090530A1 Complexes containing glycosyl-phosphatidylinositol proteins and cholanic acid derivatives, a process for their preparation and their use
08/29/1993	CA2089966A1 Antigen binding proteins and methods for their production
08/25/1993	EP0557076A1 Selective removal of N-terminal extensions from folded insulin precursors using dipeptidyl-aminopeptidase-1
08/25/1993	EP0556962A1 Small peptide and pseudopeptide amides inhibiting the proliferation of small-cell and epithelial-cell lung cancer cells
08/25/1993	EP0556726A1 Process for stabilisation of proteins
08/25/1993	EP0556651A2 Human neuronal beta-subunits of voltage-dependent calcium channels and use of the same
08/25/1993	EP0556482A2 Propyl endopeptidase inhibitor
08/25/1993	EP0556405A1 Pseudopentapeptides with immunomodulating activity
08/25/1993	EP0556395A1 Novel cytokine
08/25/1993	EP0556345A1 Retroviral vectors useful for gene therapy.
08/25/1993	EP0556344A1 New insulin-like growth factor binding protein (igfbp-6)
08/25/1993	EP0556339A1 Chinese hamster ovary cell retrovirus-like c particles
08/25/1993	EP0556333A1 Avirulent microbes and uses therefor: salmonella typhi
08/25/1993	EP0556328A1 Bridging antibody fusion constructs
08/25/1993	EP0556292A1 Hepatitis c virus asialoglycoproteins
08/25/1993	EP0556231A1 Method and composition for controlling proliferation of cells
08/25/1993	EP0556214A1 Process for amplifying nucleic acid
08/25/1993	EP0556207A1 Modified human tnfalpha (tumor necrosis factor alpha) receptor
08/25/1993	EP0556182A1 Dna capable of site-specific integration into mycobacteria
08/25/1993	EP0556178A1 Use of protease nexin-i to mediate wound healing
08/25/1993	EP0556171A1 Growth hormone antagonists
08/25/1993	EP0555405A4 Specific detection of antibodies to human t-cell leukemia viruses
08/25/1993	EP0483271B1 Peptides containing diamino-glycols as transition-state mimics
08/25/1993	EP0342215B1 Method of diagnosing blood clots using fibrin-binding proteins
08/25/1993	EP0199801B1 Methods for protein binding enzyme complementation assays
08/25/1993	CA2090278A1 Prostaglandin e receptors, their dna and production
08/24/1993	US5239066 Isolated nucleic acid having transcriptional and translational initiation and termination regions linked with yversinia ail gene encoding region
08/24/1993	US5239061 Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin
08/24/1993	US5239060 Muscular dystrophy protein, dystrophin
08/24/1993	US5239059 Ion-channel forming peptides
08/24/1993	US5239058 Selectively inhibit coagulation factor Xa
08/24/1993	US5239056 Peptide fractions which induce antibodies protecting against the bovine leukemia virus, a process for obtaining such fractions, their coding sequences and vaccines made from such fractions
08/24/1993	US5238963 Treatment with compound to prevent crosslinking of glycosylation products
08/24/1993	US5238925 Angiogenic factor isolated from live yeast cell derivatives and its use in treating wounds or burns in mammals
08/24/1993	US5238923 Amino-substituted heterocycles as renin inhibitors
08/24/1993	US5238920 Pulmonary surfactant protein fragments
08/24/1993	US5238919 Amino acid sequences corresponding to von Willebrand factor fragments; inhibit binding to platelets, heparin, collagen
08/24/1993	US5238916 Stimulates proliferation of mesodermal cells and growth of capillaries, promotes tissue repair
08/24/1993	US5238839 Nucleic Acids Encoding proteins which induce immunological effector cell activation and chemattraction, vectors, and recombinant cells
08/24/1993	US5238836 Genetic engineering; isolated DNA sequences
08/24/1993	US5238823 Interleukin-2-leukotoxin gene fusions and uses thereof
08/24/1993	US5238822 Gene expression in yeast cells
08/24/1993	US5238820 Multiply-amplifiable vectors for high level expression of exogenuos DNA
08/24/1993	US5238819 Diagnostic assay for the detection of preeclampsia
08/24/1993	CA1321676C Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
08/24/1993	CA1321582C Disulfur analogs of ll-e33288 antitumor agents
08/19/1993	WO1994015967A1 Agents for the prevention and treatment of parkinson's disease
08/19/1993	WO1993016199A1 PEPTIDE FOR DIAGNOSING AND IMMUNIZING AGAINST T. cruzi INFECTION
08/19/1993	WO1993016197A1 Nucleotide sequences and materials and methods for the diagnosis of myotonic dystrophy
08/19/1993	WO1993016196A2 Myotonic dystrophy
08/19/1993	WO1993016193A1 Cell adhesion inhibiting antibody and cell adhesion inhibitor containing the same
08/19/1993	WO1993016191A1 Empty major histocompatibility class ii heterodimers
08/19/1993	WO1993016190A1 Bacterial macromolecule extract, method for preparing same and pharmaceutical composition containing said extract
08/19/1993	WO1993016186A1 Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin
08/19/1993	WO1993016183A1 Cyclophilin associated membrane proteins dna sequences
08/19/1993	WO1993016182A1 Cloning and functional expression of cholecystokinin receptor-encoding dna
08/19/1993	WO1993016181A1 A 90k tumor-associated antigen, ir-95
08/19/1993	WO1993016180A2 Sequences for a 90k tumor-associated antigen, immunoregulin-95 (ir-95)
08/19/1993	WO1993016179A1 MAMMALIAN Sos - A REGULATOR/EFFECTOR OF TYROSINE KINASE SIGNALLING
08/19/1993	WO1993016178A2 Sequences characteristic of human gene transcription product
08/19/1993	WO1993016172A1 Mycobacterial species-specific reporter mycobacteriophages
08/19/1993	WO1993016170A1 Genetically engineered transmissible hypovirulence
08/19/1993	WO1993016107A1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes
08/19/1993	WO1993016106A1 Novel megakaryocyte amplifier and production thereof
08/19/1993	WO1993016105A1 Phenylalanine analogs of bombesin
08/19/1993	WO1993016104A1 New hexapeptidic derivatives, preparation, method and application as medicaments of said new derivatives
08/19/1993	WO1993016102A1 Human cd26 and methods for use
08/19/1993	WO1993016101A1 Beta-amyloid peptide production inhibitors and methods for their identification
08/19/1993	WO1993016099A2 Dna sequences encoding novel growth/differentiation factors
08/19/1993	WO1993016096A1 Recombinant gibberellin dna and uses thereof
08/19/1993	WO1993016087A2 Amadori reaction compounds and products, process for their manufacture, and their use
08/19/1993	WO1993015771A1 Ligands for improving metal chelate formation kinetics
08/19/1993	WO1993015770A1 Radiolabelled peptide compounds
08/19/1993	WO1993015766A1 Desensitization to specific allergens
08/19/1993	WO1993015764A1 Treatment for inflammatory bowel disease
08/19/1993	WO1993015763A1 Vaccinal polypeptides
08/19/1993	WO1993015762A1 Feline infectious peritonitis vaccine and method of preparation
08/19/1993	WO1993015758A1 Composition and method of immunization with improved carrier and hapten-carrier vaccines
08/19/1993	WO1993015756A1 Inhibitors of thrombosis
08/19/1993	WO1993015755A1 Protease-resistant thrombomodulin analogs
08/19/1993	WO1993015750A1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens
08/19/1993	WO1993015747A1 A method of using cd4-containing molecules to substantially reduce the risk of occupational hiv transmission
08/19/1993	WO1993015743A1 Novel gene therapies employing antisense constructs
08/19/1993	WO1993015608A1 Prevention of retinal injury and degeneration by specific factors
08/19/1993	WO1993015109A3 Parathyroid hormone fragments, their preparation and medicaments containing the same
08/19/1993	DE4219696A1 Hybrid-dna, plasmide, oligohybridpeptid und impfstoff Hybrid dna, plasmids, and oligohybridpeptid vaccine
08/19/1993	DE4204103A1 New gamma-amino butyric acid permease gene - for growth inhibition of microbial or plant cells or as selectable marker
08/19/1993	CA2130106A1 Amadori reaction compounds and products, process for their manufacture, and their use
08/19/1993	CA2129533A1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes

1 ... 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 ... 2916